395948003: Poloxamer 188 (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Surfactant (substance)\Poloxamer 188 (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Gastrointestinal agent (substance)\Cathartic\Laxative (substance)\Emollient cathartic (substance)\Poloxamer 188 (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide\Protein\Lipoprotein\Poloxamer 188 (substance)

\Organic compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide\Protein\Lipoprotein\Poloxamer 188 (substance)
\Organic compound\Lipid\Lipoprotein\Poloxamer 188 (substance)

\Biological substance\Protein and/or protein derivative\Protein\Lipoprotein\Poloxamer 188 (substance)
\Biological substance\Polypeptide\Protein\Lipoprotein\Poloxamer 188 (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

2572616019 Poloxamer 188 (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

2576223012 Poloxamer 188 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

834431000172114 poloxamère 188 fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Poloxamer 188 (substance)	Is a	Cathartic	false	Inferred relationship	Some
Poloxamer 188 (substance)	Is a	Synthetic polymer	false	Inferred relationship	Some
Poloxamer 188 (substance)	Is a	Surfactant	false	Inferred relationship	Some
Poloxamer 188 (substance)	Is a	Stool softener	false	Inferred relationship	Some
Poloxamer 188 (substance)	Is a	Surfactant (substance)	true	Inferred relationship	Some
Poloxamer 188 (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Surfactant (disposition)	true	Inferred relationship	Some
Poloxamer 188 (substance)	Is a	Emollient cathartic (substance)	true	Inferred relationship	Some
Poloxamer 188 (substance)	Is a	excipient pharmaceutique	false	Inferred relationship	Some
Poloxamer 188 (substance)	Is a	Lipoprotein	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely dantron 25 milligram and poloxamer 188 200 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Poloxamer 188 (substance)	Inferred relationship	Some
Dantron + poloxamer 25mg/200mg/5mL s/f oral suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Poloxamer 188 (substance)	Inferred relationship	Some
Dantron + poloxamer strong 75mg/1000mg/5mL oral suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Poloxamer 188 (substance)	Inferred relationship	Some
Product containing precisely dantron 37.5 milligram and poloxamer 188 500 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Poloxamer 188 (substance)	Inferred relationship	Some
Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Poloxamer 188 (substance)	Inferred relationship	Some
Product containing dantron and poloxamer 188 (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Poloxamer 188 (substance)	Inferred relationship	Some	2
Product containing precisely dantron 25 milligram and poloxamer 188 200 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Poloxamer 188 (substance)	Inferred relationship	Some	2
Product containing precisely dantron 25 milligram and poloxamer 188 200 milligram/1 each conventional release oral capsule (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Poloxamer 188 (substance)	Inferred relationship	Some	2
Product containing precisely dantron 37.5 milligram and poloxamer 188 500 milligram/1 each conventional release oral capsule (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Poloxamer 188 (substance)	Inferred relationship	Some	1
Product containing precisely dantron 37.5 milligram and poloxamer 188 500 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Poloxamer 188 (substance)	Inferred relationship	Some	2
Product containing precisely dantron 37.5 milligram and poloxamer 188 500 milligram/1 each conventional release oral capsule (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Poloxamer 188 (substance)	Inferred relationship	Some	2
Product containing precisely dantron 25 milligram and poloxamer 188 200 milligram/1 each conventional release oral capsule (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Poloxamer 188 (substance)	Inferred relationship	Some	2
Dantron- and poloxamer 188-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Poloxamer 188 (substance)	Inferred relationship	Some	2
Product containing precisely dantron 37.5 milligram and poloxamer 188 500 milligram/1 each conventional release oral capsule (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Poloxamer 188 (substance)	Inferred relationship	Some	1
Dantron 15 mg/mL and poloxamer 188 200 mg/mL oral suspension	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Poloxamer 188 (substance)	Inferred relationship	Some	2
Dantron 15 mg/mL and poloxamer 188 200 mg/mL oral suspension	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Poloxamer 188 (substance)	Inferred relationship	Some	2
Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Poloxamer 188 (substance)	Inferred relationship	Some	2
Dantron 5 mg/mL and poloxamer 188 40 mg/mL oral suspension	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Poloxamer 188 (substance)	Inferred relationship	Some	2
Dantron and poloxamer 188 only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Poloxamer 188 (substance)	Inferred relationship	Some	2
Product containing poloxamer 188 (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Poloxamer 188 (substance)	Inferred relationship	Some	1
Product containing poloxamer 188 in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Poloxamer 188 (substance)	Inferred relationship	Some	1
Dantron and poloxamer 188 only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Poloxamer 188 (substance)	Inferred relationship	Some	2
Product containing only poloxamer 188 (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Poloxamer 188 (substance)	Inferred relationship	Some	1
Poloxamer 188 only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Poloxamer 188 (substance)	Inferred relationship	Some	1
Product containing precisely dantron 37.5 milligram and poloxamer 188 500 milligram/1 each conventional release oral capsule (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Poloxamer 188 (substance)	Inferred relationship	Some	2

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
2572616019	Poloxamer 188 (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
2576223012	Poloxamer 188	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
834431000172114	poloxamère 188	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module